T3S (p.Thr3Ser) variant of CDK4 (Cyclin-dependent kinase 4)

T3S (p.Thr3Ser) in CDK4 (Cyclin-dependent kinase 4) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

T3S (p.Thr3Ser) variant details